These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27259806)

  • 1. Global research trends in the medical therapy of pulmonary arterial hypertension 2000-2014.
    Schreiber C; Edlinger C; Eder S; Ausserwinkler M; Wernly B; Pretsch I; Jung C; Hoppe UC; Lichtenauer M
    Pulm Pharmacol Ther; 2016 Aug; 39():21-7. PubMed ID: 27259806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Goal-oriented therapy in paediatric pulmonary arterial hypertension: are we ready?
    Beghetti M
    Eur Respir J; 2014 Dec; 44(6):1404-7. PubMed ID: 25435526
    [No Abstract]   [Full Text] [Related]  

  • 3. The evolution of prostacyclins in pulmonary arterial hypertension: from classical treatment to modern management.
    Burger CD; D'Albini L; Raspa S; Pruett JA
    Am J Manag Care; 2016 Jan; 22(1 Suppl):S3-15. PubMed ID: 26885569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trials in group 3 pulmonary hypertension.
    Harder EM; Waxman AB
    Curr Opin Pulm Med; 2020 Sep; 26(5):391-396. PubMed ID: 32657833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of pulmonary hypertension.
    Hoeper MM; McLaughlin VV; Dalaan AM; Satoh T; Galiè N
    Lancet Respir Med; 2016 Apr; 4(4):323-36. PubMed ID: 26975811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging drugs for pulmonary hypertension.
    Girgis RE
    Expert Opin Emerg Drugs; 2010 Mar; 15(1):71-85. PubMed ID: 20095920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What's the (end) point?
    Ploegstra MJ; Berger RM
    Eur Respir J; 2015 Mar; 45(3):854-5. PubMed ID: 25726540
    [No Abstract]   [Full Text] [Related]  

  • 8. What's the (end) point?
    Ventetuolo CE; Kawut SM
    Eur Respir J; 2015 Mar; 45(3):853-4. PubMed ID: 25726539
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of Pulmonary Arterial Hypertension.
    Weatherald J; Varughese RA; Liu J; Humbert M
    Semin Respir Crit Care Med; 2023 Dec; 44(6):746-761. PubMed ID: 37369218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of pulmonary arterial hypertension].
    Roman A; López-Meseguer M; Domingo E
    Med Clin (Barc); 2015 Jun; 144(12):566-70. PubMed ID: 25070518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy in pulmonary arterial hypertension.
    Pugh ME; Hemnes AR; Robbins IM
    Clin Chest Med; 2013 Dec; 34(4):841-55. PubMed ID: 24267308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The current pharmacotherapy of pulmonary arterial hypertension].
    Betkier-Lipińska K; Ryczek R; Cwetsch A
    Pol Merkur Lekarski; 2015 Jan; 38(223):34-8. PubMed ID: 25763586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary Arterial Hypertension-Specific Drug Therapy in COPD Patients with Severe Pulmonary Hypertension and Mild-to-Moderate Airflow Limitation.
    Calcaianu G; Canuet M; Schuller A; Enache I; Chaouat A; Kessler R
    Respiration; 2016; 91(1):9-17. PubMed ID: 26492415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of sarcoidosis-associated pulmonary hypertension: A single centre retrospective experience using targeted therapies.
    Keir GJ; Walsh SL; Gatzoulis MA; Marino PS; Dimopoulos K; Alonso R; Raposeiras-Roubin S; Renzoni EA; Maher TM; Wells AU; Wort SJ
    Sarcoidosis Vasc Diffuse Lung Dis; 2014 Jul; 31(2):82-90. PubMed ID: 25078636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and advancing treatments for pulmonary arterial hypertension in childhood.
    Zijlstra WM; Ploegstra MJ; Berger RM
    Expert Rev Respir Med; 2014 Oct; 8(5):615-28. PubMed ID: 25047735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Pulmonary Arterial Hypertension-specific Therapy in Pulmonary Arterial Hypertension: A Meta-analysis of Randomized Controlled Trials.
    Liu HL; Chen XY; Li JR; Su SW; Ding T; Shi CX; Jiang YF; Zhu ZN
    Chest; 2016 Aug; 150(2):353-66. PubMed ID: 27048870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary arterial hypertension: a current review of pharmacological management.
    Sahni S; Ojrzanowski M; Majewski S; Talwar A
    Pneumonol Alergol Pol; 2016; 84(1):47-61. PubMed ID: 26693827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual phosphodiesterase type 5 inhibitor therapy for refractory pulmonary arterial hypertension: a pilot study.
    Kimura M; Tamura Y; Takei M; Yamamoto T; Ono T; Fujita J; Kataoka M; Kuwana M; Satoh T; Fukuda K
    BMC Pulm Med; 2015 May; 15():62. PubMed ID: 25971443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on pulmonary arterial hypertension pharmacotherapy.
    Velayati A; Valerio MG; Shen M; Tariq S; Lanier GM; Aronow WS
    Postgrad Med; 2016 Jun; 128(5):460-73. PubMed ID: 27232660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pulmonary hypertension : What is new in therapy?].
    Sommer N; Hecker M; Tello K; Richter M; Liebetrau C; Weigand MA; Seeger W; Ghofrani A; Gall H
    Anaesthesist; 2016 Aug; 65(8):635-52. PubMed ID: 27492004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.